| Literature DB >> 31706504 |
Vinicius Kannen1, Lee Parry2, Francis L Martin3.
Abstract
Intestinal microbiota undergo significant changes in colorectal cancer (CRC). Zheng et al. (Nat. Biomed. Eng., 2019) observe detrimental overpopulation of Fusobacterium nucleatum in mice and patients, suppressing the beneficial butyrate-producing Clostridium butyricum. Phage-guided irinotecan-loaded dextran nanoparticles promote release of bacterial-derived butyrate, while F. nucleatum and CRC cells are eliminated. These findings describe a possible novel therapeutic strategy for CRC.Entities:
Keywords: bacteriophage; chemotherapy; colorectal cancer; microbiota
Year: 2019 PMID: 31706504 DOI: 10.1016/j.trecan.2019.08.002
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025